Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

BACKGROUND: Hormone receptor status and HER2 status are of critical interest in determining the prognosis of breast cancer patients. Their status is routinely assessed by immunohistochemistry (IHC). However, it is subject to intra-laboratory and inter-laboratory variability. The aim of our study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouttet, D., Laé, M., Caly, M., Gentien, D., Carpentier, S., Peyro-Saint-Paul, H., Vincent-Salomon, A., Rouzier, R., Sigal-Zafrani, B., Sastre-Garau, X., Reyal, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735463/
https://www.ncbi.nlm.nih.gov/pubmed/26829108
http://dx.doi.org/10.1371/journal.pone.0146474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735463/
https://www.ncbi.nlm.nih.gov/pubmed/26829108
http://dx.doi.org/10.1371/journal.pone.0146474

Ejemplares similares